Home / Health / Smartwatches to Predict Cancer Risk for NHS Patients
Smartwatches to Predict Cancer Risk for NHS Patients
5 Feb
Summary
- NHS patients to receive real-time cancer risk insights.
- Wearable tech data to be integrated with medical records.
- Multi-cancer early detection tests to be piloted by NHS.
Within the next decade, NHS patients will have access to real-time, personalized insights regarding their cancer risk. This national plan involves combining information from medical records, DNA analysis, demographic data, and lifestyle habits with data from clinically validated wearable technology such as smartwatches. The NHS app will serve as a central 'dashboard for cancer prevention,' providing users with advice on habits to reduce their risk.
Furthermore, the plan aims to integrate tests capable of detecting multiple cancers before symptoms appear into NHS screening programs. These early detection blood tests, like those being piloted in the Galleri trial, have the potential to significantly transform diagnosis and allow for earlier treatment. By 2035, all cancer patients will have the option for comprehensive genomic analysis.
The initiative is part of a broader strategy to improve cancer survival rates in the UK. Health minister Wes Streeting, who has personal experience with cancer, is championing this
